Schultz MK - Search Results

1

Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors.

Lee D, Li M, Liu D, Baumhover NJ, Sagastume EA, Marks BM, Rastogi P, Pigge FC, Menda Y, Johnson FL, Schultz MK. Lee D, et al. Among authors: schultz mk. Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1147-1162. doi: 10.1007/s00259-023-06494-9. Epub 2023 Nov 13. Eur J Nucl Med Mol Imaging. 2024. PMID: 37955792 Free PMC article.

2

Automated cassette-based production of high specific activity [^203/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer.

Li M, Zhang X, Quinn TP, Lee D, Liu D, Kunkel F, Zimmerman BE, McAlister D, Olewein K, Menda Y, Mirzadeh S, Copping R, Johnson FL, Schultz MK. Li M, et al. Among authors: schultz mk. Appl Radiat Isot. 2017 Sep;127:52-60. doi: 10.1016/j.apradiso.2017.05.006. Epub 2017 May 10. Appl Radiat Isot. 2017. PMID: 28521118 Free PMC article.

3

^203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer.

Li M, Sagastume EA, Lee D, McAlister D, DeGraffenreid AJ, Olewine KR, Graves S, Copping R, Mirzadeh S, Zimmerman BE, Larsen RH, Johnson FL, Schultz MK. Li M, et al. Among authors: schultz mk. Curr Med Chem. 2020;27(41):7003-7031. doi: 10.2174/0929867327999200727190423. Curr Med Chem. 2020. PMID: 32720598 Free PMC article. Review.

4

Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma.

Li M, Liu D, Lee D, Cheng Y, Baumhover NJ, Marks BM, Sagastume EA, Ballas ZK, Johnson FL, Morris ZS, Schultz MK. Li M, et al. Among authors: schultz mk. Cancers (Basel). 2021 Jul 22;13(15):3676. doi: 10.3390/cancers13153676. Cancers (Basel). 2021. PMID: 34359580 Free PMC article.

5

Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for ²⁰³Pb and ²¹²Pb-Based Theranostics.

Li M, Baumhover NJ, Liu D, Cagle BS, Boschetti F, Paulin G, Lee D, Dai Z, Obot ER, Marks BM, Okeil I, Sagastume EA, Gabr M, Pigge FC, Johnson FL, Schultz MK. Li M, et al. Among authors: schultz mk. Pharmaceutics. 2023 Jan 26;15(2):414. doi: 10.3390/pharmaceutics15020414. Pharmaceutics. 2023. PMID: 36839736 Free PMC article.

6

Optimized Methods for the Production of High-Purity ²⁰³Pb Using Electroplated Thallium Targets.

Saini S, Bartels JL, Appiah JK, Rider JH, Baumhover N, Schultz MK, Lapi SE. Saini S, et al. Among authors: schultz mk. J Nucl Med. 2023 Nov;64(11):1791-1797. doi: 10.2967/jnumed.123.265976. Epub 2023 Aug 31. J Nucl Med. 2023. PMID: 37652545

7

Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic Melanoma.

Li M, Liu D, Lee D, Kapoor S, Gibson-Corley KN, Quinn TP, Sagastume EA, Mott SL, Walsh SA, Acevedo MR, Johnson FL, Schultz MK. Li M, et al. Among authors: schultz mk. Mol Pharm. 2019 Sep 3;16(9):3904-3915. doi: 10.1021/acs.molpharmaceut.9b00512. Epub 2019 Jul 31. Mol Pharm. 2019. PMID: 31318566 Free PMC article.

8

Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry.

Baumhover NJ, Martin ME, Parameswarappa SG, Kloepping KC, O'Dorisio MS, Pigge FC, Schultz MK. Baumhover NJ, et al. Among authors: schultz mk. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5757-61. doi: 10.1016/j.bmcl.2011.08.017. Epub 2011 Aug 8. Bioorg Med Chem Lett. 2011. PMID: 21873053 Free PMC article.

9

Synthesis and Evaluation of Tetraarylethylene-based Mono-, Bis-, and Tris(pyridinium) Derivatives for Image-Guided Mitochondria-Specific Targeting and Cytotoxicity of Metastatic Melanoma Cells.

Reedy JL, Hedlund DK, Gabr MT, Henning GM, Pigge FC, Schultz MK. Reedy JL, et al. Among authors: schultz mk. Bioconjug Chem. 2016 Oct 19;27(10):2424-2430. doi: 10.1021/acs.bioconjchem.6b00394. Epub 2016 Sep 23. Bioconjug Chem. 2016. PMID: 27643916 Free PMC article.

10

Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.

Lee D, Li M, Bednarz B, Schultz MK. Lee D, et al. Among authors: schultz mk. Radiat Res. 2018 Sep;190(3):236-247. doi: 10.1667/RR15081.1. Epub 2018 Jun 26. Radiat Res. 2018. PMID: 29944461 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page